Skip to main content
. 2023 Apr 12;14:1183052. doi: 10.3389/fphar.2023.1183052

FIGURE 2.

FIGURE 2

I13 blocks cell cycle progression in CML cells. (A) K562, BaF3-WT, and BaF3-T315I cells were treated with I13 at 0.5, 0.6, or 1.1 µM, respectively, for 24 h, 48 h, or 72 h. (B) A bar graph presenting the population of G0/G1 phase cells (*p < 0.05, **p < 0.01).